Background
Tuberculosis (TB) caused by Mycobacterium tuberculosis remains a major global health problem. It is the second leading cause of death worldwide. Drug resistance threatens global TB control with the emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) TB. The burden of MDR TB and XDR TB in India is not available as continuous surveillance for drug resistance is not carried out. This study was done to determine the drug resistance patterns to first and second line drugs among new and previously treated patients with TB.
Methods
Sputum samples were collected from 100 suspected TB patients from a tertiary care referral hospital. After digestion and decontamination, samples were stained for microscopy and cultured in liquid (MGIT) and Löwenstein Jensen (LJ) medium to isolate M. tuberculosis. Drug susceptibility testing (DST) was done against first line (streptomycin, isoniazid, rifampin and ethambutol) and second line (kanamycin, capreomycin, ofloxacin and ethionamide) drugs.
Results
Among the 100 samples, 56 were smear positives and M. tuberculosis was isolated from 61 samples cultured in MGIT and 46 in L J medium. Of which 20 (32.7%) were MDR strains. Among the MDR strains, 9 (45%) were XDR strains. Two strains were totally resistant to all the 8 drugs. The proportion of MDR and XDR was highest among the previously treated patient.
Conclusion
This study underscores the need for DST in all TB patients particularly in the previously treated patients. New drugs, novel treatment strategies and adherence to treatment are needed to effectively treat and control drug resistant TB.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.